CCR5 deficiency aggravates crescentic glomerulonephritis in mice

Area of Science:

• Immunology
• Nephrology
• Molecular Biology

Background:

• Chemokine receptor CCR5 is crucial for recruiting monocytes and T cells in inflammatory conditions.
• Renal inflammation involves complex cellular interactions and chemokine signaling pathways.
• Understanding CCR5's role in glomerulonephritis is vital for developing targeted therapies.

Purpose of the Study:

• To investigate the functional role of chemokine receptor CCR5 in a mouse model of glomerulonephritis.
• To elucidate the mechanisms by which CCR5 deficiency impacts renal inflammation and leukocyte recruitment.
• To assess the involvement of CCR1 in exacerbating kidney inflammation in the absence of CCR5.

Main Methods:

• Induction of nephrotoxic serum nephritis in wild-type and CCR5(-/-) mice.
• Quantitative analysis of renal chemokine mRNA expression (CCL5, CCL3, CCL4).
• Assessment of leukocyte infiltration, renal tissue injury, albuminuria, and survival.
• Pharmacological blockade of CCR1 using BX471 in CCR5(-/-) mice.

Main Results:

• CCR5(-/-) mice exhibited significantly higher renal expression of CCL5 and CCL3 during nephritis.
• Absence of CCR5 led to augmented monocyte and T cell infiltration, increased renal damage, and higher mortality.
• CCR1 blockade in CCR5(-/-) mice reduced chemokine expression, T cell infiltration, and glomerular crescent formation.

Conclusions:

• CCR5 deficiency exacerbates glomerulonephritis through enhanced CCL3 and CCL5-driven recruitment of T cells via CCR1.
• The study highlights a critical interplay between CCR5, CCR1, and leukocyte trafficking in renal inflammation.
• Targeting the CCL3/CCL5-CCR1 axis may offer therapeutic potential for managing severe glomerulonephritis.